IFN therapy results in an improvement of survival rates of patients with C-viral chronic hepatitis and liver cirrhosis.

被引:0
|
作者
Ohshiro, S [1 ]
Moriyama, M [1 ]
Higuchi, A [1 ]
Nasuno, K [1 ]
Matsumura, H [1 ]
Goto, I [1 ]
Tanaka, N [1 ]
Arakawa, Y [1 ]
机构
[1] Nihon Univ, Sch Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
810
引用
下载
收藏
页码:362A / 362A
页数:1
相关论文
共 50 条
  • [31] Diagnostic Accuracy of the Forns Score for Liver Cirrhosis in Patients With Chronic Viral Hepatitis
    Bukhari, Tayyaba
    Jafri, Lena
    Majid, Hafsa
    Ahmed, Sibtain
    Khan, Aysha Habib H.
    Abid, Shahab
    Raza, Aniqa
    Siddiqui, Imran
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [32] Spectrum of Endoscopic Findings in Patients with Liver Cirrhosis due to Chronic Viral Hepatitis
    Afzal, Muhammad
    Tarar, Shahida Husain
    Shah, Syed Muhammad Ali
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (01): : 10 - 13
  • [33] Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis
    Konturek, SJ
    Gonciarz, M
    Gonciarz, Z
    Bielanski, W
    Mazur, W
    Mularczyk, A
    Konturek, PC
    Goetze, JP
    Rehfeld, JF
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) : 643 - 647
  • [34] EFFECT OF IFN-β FOR PATIENTS WITH CHRONIC HEPATITIS C DISCONTINUING IFN-α THERAPY
    Shimada, Masahiko
    Yoshida, Shuhei
    Kitamuro, Yoshiaki
    Yoshino, Morihiko
    Yomoda, Masoyoshi
    Tsuchishima, Mutsumi
    Kawahara, Hiromu
    Takase, Shujiro
    HEPATOLOGY, 2008, 48 (04) : 883A - 883A
  • [35] Increased prevalence of hila class 1 allelic diversity in chronic hepatitis C patients with cirrhosis.
    Patel, K
    Norris, S
    Clare, M
    Pianko, S
    Heaton, S
    Feng, A
    Blatt, LM
    Koziol, C
    Conrad, A
    HEPATOLOGY, 2002, 36 (04) : 278A - 278A
  • [36] VARIATIONS OF VIRAL LOAD AND GENOTYPES AFTER IFN THERAPY IN CHRONIC HEPATITIS-C
    PORTA, I
    BOURLIERE, M
    HALFON, P
    GEROLAMI, V
    WARTELLE, C
    KHIRI, H
    GARNIER, PP
    CASTELLANI, P
    ANTONI, M
    BOTTAFRIDLUND, D
    GAUTHIER, AP
    CARTOUZOU, G
    GASTROENTEROLOGY, 1995, 108 (04) : A1150 - A1150
  • [37] INTERFERON (IFN) TREATMENT OF CHRONIC VIRAL HEPATITIS-C IN PATIENTS WITH COEXISTENT AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
    MOLLOY, J
    KANIA, R
    FRIEDLANDER, L
    VANTHIEL, D
    HEPATOLOGY, 1993, 18 (04) : A244 - A244
  • [38] Predictive value of liver cell dysplasia in needle liver biopsies for subsequent hepatocellular carcinoma in viral-induced chronic hepatitis and cirrhosis.
    Libbrecht, L
    Craninx, M
    Nevens, F
    Desmet, V
    Roskams, T
    HEPATOLOGY, 1999, 30 (04) : 249A - 249A
  • [39] Change of serum cholesterol fractions in patients with chronic hepatitis C after sustained viral response to IFN therapy
    Ishii, Koji
    Takamura, Naoko
    Higami, Katsuya
    Matsumaru, Katsuhiko
    Ikehara, Takashi
    Nagai, Hidenari
    Watanabe, Manabu
    Sumino, Yasukiyo
    Miki, Kazumasa
    GASTROENTEROLOGY, 2007, 132 (04) : A793 - A793
  • [40] The interferon therapy of the chronic viral hepatitis C at the hemodialysis patients
    Simionescu, Aurelian Ovidiu
    Simionescu, Livia
    Mihailescu, Ileana
    Moisa, Mircea
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 355 - 355